PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
Share   Print      RSS

Mereo BioPharma Grp (MPH)

Mereo BioPharma Grp

Block listing Interim Review
RNS Number : 1953F
Mereo BioPharma Group plc
06 March 2020
 

Mereo BioPharma Group plc

 

Block Listing Interim Review

 

Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies, Mereo BioPharma Group plc makes the following update on its block listing:

 

Date: 6 March 2020

 

Name of applicant:

Mereo BioPharma Group plc

Name of scheme:

2015 Plan

Mereo BioPharma Group plc Share Option Plan

Period of return:

From:

06/09/19

To:

06/03/20

Balance of unallotted securities under scheme(s) from previous return:

7,565,929

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:   Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

7,565,929

 

Name of contact:

Charles Sermon

Telephone number of contact:

+44 (0)333 023 7300

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRKZGGFKKNGGZM
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close